Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk for severe hypoglycemia. The aim of this study was to assess the prevalence and determinants of self-reported IAH and severe hypoglycemia in a Dutch nationwide cohort of people with insulin-treated type 2 diabetes. Research design and methods Observational study of The Dutch Diabetes Pearl, a cohort of people with type 2 diabetes treated in primary, secondary and tertiary diabetes care centers. The presence of IAH and the occurrence of severe hypoglycemia in the past year, defined as an event requiring external help to recover, were assessed using the validated Dutch ...
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients ...
Little is known about the frequency of significant hypoglycemic events in actual practice. Limited h...
AIMS: Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the f...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
ObjectivePeople with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Background: Impaired awareness of hypoglycaemia (IAH) predisposes affected patients to severe hypogl...
Objectives Hypoglycemia is a common side effect of insulin therapy in type 1 and type 2 diabetes. Li...
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients ...
Little is known about the frequency of significant hypoglycemic events in actual practice. Limited h...
AIMS: Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the f...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
ObjectivePeople with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Background: Impaired awareness of hypoglycaemia (IAH) predisposes affected patients to severe hypogl...
Objectives Hypoglycemia is a common side effect of insulin therapy in type 1 and type 2 diabetes. Li...
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients ...
Little is known about the frequency of significant hypoglycemic events in actual practice. Limited h...
AIMS: Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the f...